Prediction of Bacterial Meningitis Based on Cerebrospinal Fluid Pleocytosis in Children
Overview
Authors
Affiliations
Children with cerebrospinal fluid pleocytosis are frequently treated with parenteral antibiotics, but only a few have bacterial meningitis. Although some clinical prediction rules, such as bacterial meningitis score, are of well-known value, the cerebrospinal fluid white blood cells count can be the initial available information. Our aim was to establish a cutoff point of cerebrospinal fluid white blood cell count that could distinguish bacterial from viral and aseptic meningitis. A retrospective study of children aged 29 days to 17 years who were admitted between January 1st and December 31th, 2009, with cerebrospinal fluid pleocytosis (white blood cell≥7μL(-1)) was conducted. The cases of traumatic lumbar puncture and of antibiotic treatment before lumbar puncture were excluded. There were 295 patients with cerebrospinal fluid pleocytosis, 60.3% females, medium age 5.0±4.3 years distributed as: 12.2% 1-3 months; 10.5% 3-12 months; 29.8% 12 months to 5 years; 47.5% >5 years. Thirty one children (10.5%) were diagnosed with bacterial meningitis, 156 (52.9%) viral meningitis and 108 (36.6%) aseptic meningitis. Bacterial meningitis was caused by Neisseria meningitidis (48.4%), Streptococcus pneumoniae (32.3%), other Streptococcus species (9.7%), and other agents (9.7%). cerebrospinal fluid white blood cell count was significantly higher in patients with bacterial meningitis (mean, 4839cells/μL) compared to patients with aseptic meningitis (mean, 159cells/μL, p<0.001), with those with aseptic meningitis (mean, 577cells/μL, p<0.001) and with all non-bacterial meningitis cases together (p<0.001). A cutoff value of 321white blood cell/μL showed the best combination of sensitivity (80.6%) and specificity (81.4%) for the diagnosis of bacterial meningitis (area under receiver operating characteristic curve 0.837). Therefore, the value of cerebrospinal fluid white blood cell count was found to be a useful and rapid diagnostic test to distinguish between bacterial and nonbacterial meningitis in children.
Pentraxin 3: a novel biomarker in pediatric central nervous system infections.
El-Kady H, Mostafa M, Madkour S BMC Pediatr. 2025; 25(1):7.
PMID: 39762781 PMC: 11702170. DOI: 10.1186/s12887-024-05315-8.
Debbagh F, Harrar S, Babokh F, Hanchi A, Soraa N Cureus. 2023; 15(2):e35338.
PMID: 36851943 PMC: 9963464. DOI: 10.7759/cureus.35338.
Xiao H, Xiao H, Zhang Y, Guo L, Dou Z, Liu L Front Immunol. 2022; 13:872832.
PMID: 36119025 PMC: 9478118. DOI: 10.3389/fimmu.2022.872832.
Alnomasy S, Alotaibi B, Mujamammi A, Hassan E, Ali M PLoS One. 2021; 16(6):e0251518.
PMID: 34115780 PMC: 8195399. DOI: 10.1371/journal.pone.0251518.
Panels and Syndromic Testing in Clinical Microbiology.
Bard J, McElvania E Clin Lab Med. 2020; 40(4):393-420.
PMID: 33121611 PMC: 7528880. DOI: 10.1016/j.cll.2020.08.001.